# Hanlim Pharm. Co., Ltd.

Organization · id `cardio:org-hanlim-pharm-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Hanlim+Pharm.+Co.%2C+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Hanlim Pharm. Co., Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in Hypertension (`cardio:ct-nct03226340`)
- Sponsors: To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia (`cardio:ct-nct04659070`)
- Sponsors: Clinical Trial to Evaluate the Efficacy and Safety of Monotherapy Group of HL1113R1 or HL1113R2 Versus HL1113 (Fixed Dose Combination) in Patients With Essential Hypertension and Type II Diabetes Mellitus (`cardio:ct-nct07552389`)

## Provenance

Content hash: f8c78296bc61abada593e95a3401b1cdf7488134d26649ce561eb5205910c196
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
